<p>Roselabs Ltd plans to raise Rs 100 crore through private equity to expand its operations.<br /><br /></p>.<p>“We are looking at raising Rs 100 crore through private equity to fund our expansion plans. We are also talking to some financial institutional players to raise funds,” Roselabs Director Zameer Agarwal said.<br /><br />Ahmedabad-based Roselabs Group has set up the first of its kind complete end-to-end pre-filled syringes (PFS) making facility in the world.<br /><br />Roselabs new ventures have already invested for more than Rs 400 crore for a state-of-the-art PFS facility at Ahmedabad in Gujarat which has a capacity to manufacture 8 lakh syringes a day.<br /><br /> It has capabilities to make both glass and polymer (Cyclic Olefin Copolymer) syringes and formulation filling facilities too.</p>
<p>Roselabs Ltd plans to raise Rs 100 crore through private equity to expand its operations.<br /><br /></p>.<p>“We are looking at raising Rs 100 crore through private equity to fund our expansion plans. We are also talking to some financial institutional players to raise funds,” Roselabs Director Zameer Agarwal said.<br /><br />Ahmedabad-based Roselabs Group has set up the first of its kind complete end-to-end pre-filled syringes (PFS) making facility in the world.<br /><br />Roselabs new ventures have already invested for more than Rs 400 crore for a state-of-the-art PFS facility at Ahmedabad in Gujarat which has a capacity to manufacture 8 lakh syringes a day.<br /><br /> It has capabilities to make both glass and polymer (Cyclic Olefin Copolymer) syringes and formulation filling facilities too.</p>